Top Markets
#1 Siren Siren +33.59%
#2 Wiki Cat Wiki Cat +27.83%
#3 Ribbita by Virtuals Ribbita by Virtuals +17.67%
#4 PulseChain PulseChain +16.92%
#5 Bitway Bitway +16.87%
#6 Velvet Velvet +16.62%
#7 Cysic Cysic +15.53%
#8 TRIA TRIA +15.19%
#9 KUB Coin KUB Coin +14.61%
#10 Nockchain Nockchain +13.92%
Coin of the day
Siren Siren
설정
언어
한국어
통화
USD
테마
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
주식 순위 #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
주가
$0.089
마지막 동기화: 2026-08-17
시가총액
$15.36M
변동 (1일)
50.59%
변동 (1년)
111.85%
국가
US
거래 Inhibitor Therapeutics, Inc. (INTI)

카테고리

Healthcare
Inhibitor Therapeutics, Inc. (INTI)의 수익
2026 기준 수익 TTM: 0
Inhibitor Therapeutics, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Inhibitor Therapeutics, Inc.의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE